J.W. Burns & Co’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-37,887
Closed -$3.76M 166
2019
Q3
$3.76M Sell
37,887
-950
-2% -$90.3K 0.87% 40
2019
Q2
$3.59M Sell
38,837
-125
-0.3% -$11.9K 0.83% 41
2019
Q1
$3.68M Buy
38,962
+400
+1% +$35K 0.9% 36
2018
Q4
$2.47M Sell
38,562
-3,936
-9% -$291K 0.69% 49
2018
Q3
$3.8M Sell
42,498
-1,405
-3% -$124K 0.89% 36
2018
Q2
$3.49M Sell
43,903
-5,112
-10% -$424K 0.89% 37
2018
Q1
$4.37M Buy
49,015
+1,267
+3% +$122K 1.12% 29
2017
Q4
$4.98M Buy
47,748
+3,275
+7% +$370K 1.26% 23
2017
Q3
$6.49M Sell
44,473
-215
-0.5% -$29.3K 1.73% 13
2017
Q2
$5.8M Buy
44,688
+1,554
+4% +$190K 1.57% 17
2017
Q1
$5.37M Buy
43,134
+13,343
+45% +$1.6M 1.48% 20
2016
Q4
$3.45M Buy
29,791
+676
+2% +$75.3K 1.01% 35
2016
Q3
$3.04M Buy
29,115
+1,070
+4% +$116K 0.94% 34
2016
Q2
$2.77M Sell
28,045
-10
-0% -$1.03K 0.84% 38
2016
Q1
$2.81M Sell
28,055
-150
-0.5% -$15.4K 0.89% 36
2015
Q4
$3.38M Sell
28,205
-3,000
-10% -$347K 1.07% 28
2015
Q3
$3.38M Sell
31,205
-1,836
-6% -$228K 1.16% 28
2015
Q2
$3.82M Sell
33,041
-89
-0.3% -$10.2K 1.25% 21
2015
Q1
$3.82M Buy
33,130
+210
+0.6% +$25.1K 1.25% 22
2014
Q4
$3.68M Sell
32,920
-600
-2% -$63.3K 1.21% 26
2014
Q3
$3.18M Sell
33,520
-400
-1% -$36.1K 1.07% 31
2014
Q2
$2.91M Sell
33,920
-800
-2% -$60.8K 0.97% 36
2014
Q1
$2.42M Sell
34,720
-2,600
-7% -$206K 0.86% 39
2013
Q4
$3.15M Sell
37,320
-600
-2% -$47.5K 1.1% 25
2013
Q3
$2.92M Sell
37,920
-600
-2% -$42K 1.12% 25
2013
Q2
$2.25M Buy
+38,520
New +$2.32M 0.92% 33

Other funds holding CELG

J.W. Burns & Co's CELG Position: Q4 2019 in Review

J.W. Burns & Co sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 37,887 shares — an estimated $3.76M sold.

J.W. Burns & Co first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $6.49M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • J.W. Burns & Co reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • J.W. Burns & Co sold 37,887 Celgene Corp shares in Q4 2019, an estimated $3.76M.
  • J.W. Burns & Co first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • J.W. Burns & Co's Celgene Corp position peaked at $6.49M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on J.W. Burns & Co's 13F filing for Q4 2019, filed 7 Jan 2020.